Tuesday, 1 February 2022
Friday, 28 January 2022
Investor Ideas #Potcasts 622, #Cannabis News and #Stocks on the Move; Interview with Partner at Windels Marx Cannabis Law Practice Group
Investor Ideas #Potcasts
622, #Cannabis News and #Stocks on the Move; Interview with Partner at Windels
Marx Cannabis Law Practice Group
Vancouver, Kelowna, Delta, BC, January 28,
2022 (Investorideas.com
Newswire) www.Investoride, as.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2022/012822-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2022/cannabis-potcasts/01281Windels-Marx-Cannabis-Law-Practice-Group.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast Investorideas interviews Karl Frederik, Partner at Windels Marx Cannabis Law
Practice Group, where we discussed cannabis legislation, with specific focus on
New York and New Jersey where Frederik is based out of, as well as how he
anticipates regulatory change evolving on both a state and federal level.
Frederik
has an extensive background in law which eventually brought him into the
cannabis space in 2015. “I’ve been practicing law for over 30 years,
predominantly in real estate and urban redevelopment and construction and my
practice focus has been in healthcare and on the pharmaceutical industry as
well as consumer packaged goods. In 2014 I successfully completed an unrelated
campaign related to family law reform. I worked on that project with a lobbyist
named Michael Turner from Burton Trent LLC, he’s one
of the top lobbyists in New Jersey. So we sat down and I said “Well look we
accomplished the impossible in 2014, what are we going to do in 2015?” and he
said “we’re going to work on legalizing cannabis”. So starting in 2015 I
started studying the industry and talking with people and then Governor Murphy
came along and said “I’m making this a legislative priority if I’m elected”. So
Governor Murphy was elected, poll results came in around 8:00pm in the evening
and by 8:30pm I had my plane tickets to go to MJBIZCon in Las Vegas. As an
outgrowth of the lobbying efforts, Michale Turner and his team formed the New
Jersey Cannabusiness Association to support the burgeoning industry
and I became their first outside council. Through those efforts I was able to
influence marijuana policy in New Jersey and do comparison and contrast with
what worked and didn’t work in other jurisdictions.”
At
Windels Marx. Frederik brings together
disciplines in real estate, corporate, tax, governmental affairs, pharmaceutical
new drug applications, intellectual property and related areas of law to
provide applicants, licensees, developers, businesses and investors a practical
understanding of the landscape so they can capitalize on cannabis industry
opportunities.
Speaking
about the current landscape of the New Jersey Cannabis industry and the
competition between large scale MSO’s and smaller scale operations, Frederik
commented, “this is really part of the tension in the industry when you have a
robust medical program. Curaleaf and TerrAscend are already in New Jersey, TerrAscend has one of the largest grows in New
Jersey to feed its Apothecarium brand of stores. They are precisely the groups
that are looking to move to recreational sales. In the same token, and this is
a parallel issue in New York, a lot of small operators are going for relatively
limited licenses. We are prioritizing in New Jersey, social equity applicants
but the issue is getting them financing and one cannot underestimate the amount
it takes to start a serious medical cannabis operation. So what we are seeing
from the small operators who are going after processing licenses and smaller
cultivation licenses but the MSO’s are here and they’re not going anywhere.”
Frederik
went on to discuss some of the taxation issues different states are facing,
specifically California’s cultivation tax, as well as how other states have
adjusted their licensing and taxation schemes to benefit their local cannabis
industries.
“In
the East Coast the lesson is being learned.” commented Frederik on how states
like New York and New Jersey have adjusted their policies after seeing some of
the issues that have arisen in states like California and Colorado.
Frederik
went on to discuss the issues in almost all states with regards to the legal
market competing with the “grey” or “legacy” market, commenting, “we’ve noted
that there is a delay between decriminalization and legalization. We have
decriminalized in New York and New Jersey, but there is this block of time
where the “legacy” market or “grey” market has an opportunity to take a real
foothold. Now in New Jersey I would argue that we are moving at a speed that would
permit us to create a marketplace that will be able to successfully compete
with the legacy market. New York being so far behind, has one of the largest,
if not the largest, legacy markets in the country. That market will only build
a more firm foothold and a larger clientele moving forward and the degree to
which that legacy market can take a foothold becomes a potential challenge for
building the legal market as has happened in California. It’s fascinating to
see how this plays out.”
Frederik
also discussed the social equity programs of New York and New Jersey in more
detail, how this impacts the industry, how the advocacy for psychedelics is
aiding education surrounding cannabis and plant medicines as well as how he
sees legalization progressing and evolving on a state level and if/when we
could see any movement on a federal level.
To
find out more information about Karl Frederik and Wendels Marx click here.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com
podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com
podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com -
News that Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third party stock research, guest posts and
original articles and podcasts in leading stock sectors. Learn about investing in stocks and get
investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy, gaming and more. Investor Idea’s original branded content
includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the
Move podcast , Cleantech and Climate
Change , Exploring Mining , Betting on Gaming Stocks
Podcast
and the AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Thursday, 27 January 2022
Tuesday, 25 January 2022
Friday, 21 January 2022
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...